Applied Biosciences Corp.
APPB · OTC
3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | |
|---|---|---|---|---|
| Market Cap | $2,741 | $109,649 | $158,225 | $301,428 |
| - Cash | $0 | $525 | $47 | $61 |
| + Debt | $273 | $387 | $25 | $0 |
| Enterprise Value | $3,014 | $109,511 | $158,203 | $301,367 |
| Revenue | $89 | $723 | $707 | $198 |
| % Growth | -87.7% | 2.3% | 257.9% | – |
| Gross Profit | -$318 | $287 | $185 | $42 |
| % Margin | -358.5% | 39.6% | 26.2% | 21.3% |
| EBITDA | -$725 | -$3,753 | -$1,990 | -$2,162 |
| % Margin | -817.9% | -518.8% | -281.4% | -1,094.4% |
| Net Income | -$767 | -$4,674 | -$2,629 | -$2,376 |
| % Margin | -865.3% | -646.1% | -371.9% | -1,202.8% |
| EPS Diluted | -0.056 | -0.34 | -0.22 | -0.16 |
| % Growth | 83.5% | -54.5% | -37.5% | – |
| Operating Cash Flow | -$750 | -$1,243 | -$905 | -$673 |
| Capital Expenditures | $0 | -$1 | -$2 | -$5 |
| Free Cash Flow | -$750 | -$1,244 | -$907 | -$678 |